Full-Time

Senior Manager Data Engineer

GPS Analytics and AI Enablement

Confirmed live in the last 24 hours

Deadline 8/4/25
Bristol Myers Squibb

Bristol Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Compensation Overview

$135k - $163.6k/yr

+ Incentive Cash + Stock Opportunities

Senior

Company Historically Provides H1B Sponsorship

Franklin Township, NJ, USA

Hybrid

Category
Data Science
Data Engineering
Data & Analytics
Required Skills
Redshift
Python
Data Science
Git
Machine Learning
AWS
Development Operations (DevOps)
Data Analysis
Requirements
  • Minimum 7-8 years of experience with Information Technology and Information Management systems, designing, implementing, and/or supporting analytic platforms (data warehouse, data hub, ETL/transformations, and/or Business Intelligence) related activities satisfying complex information needs within the life sciences industry
  • Hands-on expertise in AWS technologies and Python
  • Experience with applying AI/ML technologies in data Engineering and analytics
  • Must have broad technology expertise, working knowledge of life sciences manufacturing business processes, with demonstrated command of key concepts, systems, and processes
  • Experience with Big Data, Master Data Management (MDM), Data Visualization, and/or Data Virtualization for both structured and/or unstructured data
  • Experience in working in geographically dispersed teams and virtual collaboration
Responsibilities
  • Solution architect to design and model new data enablement projects to enable analysts and scientists’ team to take out some insights from data.
  • Based on design and model lead the projects and perform end to end delivery
  • Lead requirement gathering discussions with business to understand the business challenges and design solution.
  • Technical point of contact for AWS services and helps/support technical team to resolve technical issues.
  • Perform code review for provide feedback and fix issues in the code.
  • Provide technical support to end users to resolve issues specific to AWS services ie Athena, and other AWS services.
  • Evaluate emerging technologies in data and analytics area, perform technical pilots if necessary and share read out with leadership team.
  • Own and maintain git repository for code base.
  • Lead implementation of GxP (validated) projects.
  • Technical SME to operate and develop data and analytics focused capabilities in support of the Product Development Data Enablement BIT Organization
  • Ability to setup data ingestion pipelines in GPS datalakes using AWS services ie glue studio, S3, Lambda
  • Hands-on experience with DevOps practices and tools for continuous integration and continuous deployment (CI/CD).
  • Hands on experience in Python, AWS services Redshift/S3/ RDS/Athena, Native AWS Services, Database design and familiarity with Domino/data lake principles
  • Come up with automation, innovation ideas and implement them in datalakes
  • Hands on modeling experience to build data models (Conceptual and Logical data models)
  • Strong analytical skills to troubleshoot and resolve data-related issue
Desired Qualifications
  • Prior experience in global life sciences especially in the GPS functional area will be a plus
  • Prior experience in Cloud technologies – preferably AWS and related capabilities such as storage, compute, catalogue, data virtualization will be a huge plus
  • Prior experience working in jira
  • Experience working internationally with a globally dispersed team including diverse stakeholders i.e. offshore technical development team(s)
  • Strong communication and presentation skills

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, particularly in oncology, immunology, and cardiovascular health. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs that are affordable alternatives to their innovative medicines, ensuring they meet high quality and safety standards. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, along with a strong commitment to sustainability and corporate responsibility. The company's goal is to improve patient outcomes by providing effective and affordable healthcare solutions while adhering to Environmental, Social, and Governance (ESG) principles.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • Chris Shibutani's appointment may drive strategic growth and innovation at BMS.
  • Advancements in targeted protein degradation enhance therapeutic offerings in oncology.
  • Partnership with BioNTech could provide a competitive edge against Merck's Keytruda.

What critics are saying

  • Antitrust litigation over Pomalyst could impact BMS's market position in oncology.
  • Reliance on real-world data presents challenges in data quality and implementation.
  • High costs and technical challenges in space research could affect treatment feasibility.

What makes Bristol Myers Squibb unique

  • BMS collaborates with BioNTech for next-gen cancer immunotherapy, enhancing oncology portfolio.
  • Focus on real-world data strategies could lead to faster drug market entry.
  • Developing bone disease treatments in space positions BMS as a leader in innovative research.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Company News

ISS National Lab
Jul 7th, 2025
This is Not the Time to Cut Space-enabled Medical Research

Bristol-Myers Squibb is developing novel bone disease treatments in space, and the National Stem Cell Foundation is studying 3D brain organoids derived from patients with Parkinson's disease in microgravity to observe disease progression more rapidly with the aim of identifying potential biomarkers for early diagnosis and therapeutic targets.

The Pharma Letter
Jun 26th, 2025
Bristol Myers faces new antitrust suit over multiple myeloma drug Pomalyst

Bristol Myers faces new antitrust suit over multiple myeloma drug Pomalyst.

Unlearn
Jun 24th, 2025
The Best 15 Minutes You'll Spend on Clinical Trials Today

At the 2025 "Digital Breakthrough for Pharma" Summit hosted by Bristol Myers Squibb, Unlearn's co-founder and machine learning scientist, Aaron Smith, took the stage to explain exactly how that vision is now a reality.

ROI-NJ
Jun 13th, 2025
Bristol Myers Squibb Names Shibutani As Evp, Chief Strategy Officer

Bristol Myers Squibb (BMS) this week appointed Chris Shibutani as executive vice president, chief strategy officer, effective immediately. Shibutani’s role is a new position on the BMS leadership team. The announcement was made on a LinkedIn post.Shibutani will lead the development and advancement of the company’s long-term strategic plan, collaborating across the enterprise to drive innovation and growth. He brings more than 25 years of experience in the financial services industry covering global pharmaceutical, biotechnology and medical device industries.Prior to BMS, Shibutani served as managing director in the global investment research division at Goldman Sachs. Previous roles include senior analyst positions at Hambrecht & Quist, Cowen, UBS, and J.P. Morgan.Before his career in finance, Shibutani was a physician trained in anesthesiology and critical care medicine at Massachusetts General Hospital and practiced at Memorial Sloan Kettering Cancer Center

PharmaData
Jun 13th, 2025
Bristol Myers Squibb Highlights Targeted Protein Degradation Data, Including CELMoD Agents, at EHA 2025

Bristol Myers Squibb highlights targeted protein degradation advances, including CELMoD agents and BCL6 Ligand-Directed Degrader, at EHA 2025 in Milan, Italy.